Quest Diagnostics Inc $58.35

down -0.05


23/4/2014 06:40 PM  |  NYSE : DGX  
Industries : Health Services / Medical Laboratories & Research
Get Trend Analysis Icon Get DGX Trend Analysis - it has underperformed the S&P 500 by 16%

Partner Headlines

  1. Quest Diagnostics Extends Partnership with Steward Health Care System

    Benzinga
  2. Medical Diagnostic Labs Facing Medicare Headwinds

    GuruFocus
  3. Morning Coffee: Stocks at Historical Low P/B and P/S

    GuruFocus
  4. Myriad Stock Tumbles After Court Allows Rival To Sell

    IBD
  5. US Stock Futures Edge Lower Ahead Of Wholesale Trade Data

    Benzinga
  6. Diamond Hill Capital Comments on Quest Diagnostics

    GuruFocus
  7. Stocks Hitting 52-Week Lows

    Benzinga
  8. UPDATE: Quest Diagnostics Posts Higher Q4 Profit, Issues Downbeat 2014 ...

    Benzinga
  9. Earnings Scheduled For January 30, 2014

    Benzinga
  10. Quest Buys Solstas Lab for $570M

    FoxBusiness
  11. It's Time to Follow Chris Davis and Buy Laboratory Corp

    GuruFocus
  12. Quest Diagnostics Adds Timothy L. Main to Board of Directors

    Benzinga
  13. UC San Francisco, Quest Diagnostics Form Collaboration

    Benzinga
  14. Myriad Price Cut Reflects Changing Gene-Test Industry

    IBD
  15. 5 Leadership Traits That Stock Investors Should Look For

    GuruFocus
  16. Numerous Gurus Hold IDCC, DGX, PTR at 10-Year Low P/B

    GuruFocus
  17. Myriad Hit By Downgrades After Reimbursement Cut

    IBD
  18. UPDATE: JMP Securities Initiates Coverage on Quest Diagnostics on Multiple ...

    Benzinga
  19. Hologic's Opportunity (Icahn Sees It. Do You?)

    GuruFocus
  20. DGX, STO, LSE:DOM - Gurus Hold Stocks Traded at 10-Year Low P/B

    GuruFocus
  21. Quest, LabCorp Plunge: Buying Opportunity?

    YCharts
  22. UPDATE: Morgan Stanley Removes PT on Quest Diagnostics on Model Update ...

    Benzinga
  23. UPDATE: Bank of America Downgrades Quest Diagnostics on Reduced 2014 EPS ...

    Benzinga
  24. Benzinga's Top Downgrades

    Benzinga
  25. Myriad Genetics Sued On Gene Patents; Stock Falls

    IBD
  26. Dividends Are Still The Yield That Matters

    YCharts
  27. Benzinga's Top Initiations

    Benzinga
  28. Danaher Hits New High After Q3 Earnings Beat

    IBD
  29. Earnings Scheduled For October 17, 2013

    Benzinga
  30. J&J Q3 Results: Strong In Pharma, So-So Elsewhere

    IBD
  31. UPDATE: Citigroup Lowers PT on Quest Diagnostics Following Disappointing ...

    Benzinga
  32. Disappointing Preliminary Earnings from Quest Diagnostics Trickles Down ...

    Benzinga
  33. Quest Acquires ConVerge Diagnostic Services

    Benzinga
  34. Myriad Genetics Falls On Downgrade, Despite Q4 Beat

    IBD
  35. Royalty Pharma Partners with Aisling Capital and Clarus Ventures in Recent ...

    Benzinga
  36. Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry ...

    Benzinga
  37. Benzinga Market Primer: Wednesday, January 23

    Benzinga
  38. Earnings Scheduled For January 23, 2013

    Benzinga
  39. Quest selling blood test unit

    IBD
  40. Quest selling blood test unit

    IBD
  41. Quest Diagnostics Overhaul Continues With Unit Sale

    IBD
  42. Quest Diagnostics Overhaul Continues With Unit Sale

    IBD
  43. Quest Diagnostics to Sell HemoCue Diagnostic Products Business

    Benzinga
  44. Quest Diagnostics and LabCorp Stocks: Case For a Buying Opportunity

    YCharts
  45. Quest Diagnostics Buys UMass Memorial Medical Center's Outreach Lab Business

    Benzinga
  46. Bio-Reference Earnings Meet Views Despite Hurricane

    IBD
  47. UPDATE: Jefferies & Company Reiterates Hold Rating, Lowers PT on Quest ...

    Benzinga
  48. Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With ...

    Benzinga
  49. Quest Diagnostics Inc. Reports Operating Results (10-Q)

    GuruFocus
  50. Quest Diagnostics Inc: Fundamental Stock Research Analysis

    GuruFocus
Trading Center